Pembrolizumab in HER2-Positive Gastric Cancer. Janjigian YY, Kawazoe A, Bai Y, Xu J, et al. N Engl J Med 2024 Sep 14. doi: 10.1056/NEJMc2408121.

Read + Share

Amedeo Smart

Independent Medical Education

Janjigian YY, Kawazoe A, Bai Y, Xu J, et al. Pembrolizumab in HER2-Positive Gastric Cancer. N Engl J Med 2024 Sep 14. doi: 10.1056/NEJMc2408121.
PMID: 39282917